In these analyses, the risk for KS in the post-ART expansion era was 52% lower than in the pre–expansion after adjusting for age, sex, and CD4 T-cell count at the time of commencement of ART although this was not significantly significant.
← all excerpts
Incident Kaposi sarcoma during the expansion of antiretroviral therapy eligibility in Nigeria: a retrospective cohort study.
1
—
—